Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Horiguchi H, Kadomatsu T, Yamashita T, Yumoto S, Horino T, Sato M, Terada K, Miyata K, Ichigozaki Y, Kimura T, Fukushima S, Moroishi T, Oike Y.
Horiguchi H, et al. Among authors: yumoto s.
Cancer Gene Ther. 2024 Jun;31(6):933-940. doi: 10.1038/s41417-024-00757-9. Epub 2024 Mar 11.
Cancer Gene Ther. 2024.
PMID: 38467764